 |
市場調查報告書
商品編碼
1350265
兒科安寧療護藥物市場：依藥物類別、給藥途徑、通路、地區：規模、份額、前景、機會分析，2023-2030Pediatric Palliative Care Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023-2030 |
||||||
價格
簡介目錄
預計到 2023 年，全球兒科安寧療護藥物市場規模將達到 831 億美元，預計在預測期內（2023-2030 年）複合年增長率為 5.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023年市場規模 | 美國：831億美元 |
| 之前的數據 | 2018年至2021年 | 預測期 | 2023-2030 |
| 預測 2023-2030 年複合年增長率： | 5.10% | 2030年價值預測 | 1178億美元 |
兒科安寧療護是針對患有嚴重疾病的兒童的專門醫療照護。安寧療護的重點是緩解疾病症狀和壓力。目的是提高兒童和家庭的生活品質。兒科安寧療護適用於任何年齡和疾病階段。適用於新生兒、圍產期、嬰兒、兒童、青少年及青少年患者，可與治療同時進行。兒科安寧療護解決嚴重的醫療問題，如遺傳性疾病、癌症、早產、神經系統疾病、心臟病和肺部疾病。它可以緩解這些疾病的症狀，包括疼痛、氣短、疲勞、便秘、噁心、食慾不振、睡眠困難、焦慮和憂鬱。簡而言之，我們幫助改善兒童和家庭的生活品質。兒科安寧療護是一項跨學科合作，旨在改善患有危及生命疾病的兒童及其家人的生活品質。世界衛生組織 (WHO) 將兒科安寧療護定義為對兒童的身體、思想和精神進行積極、全面的護理，包括對家庭的支持。在安寧療護中最常用的藥物包括撲熱息痛、布洛芬、嗎啡、比沙可啶、甲硝唑、多潘立酮、地塞米松和地西泮。我們也治療腎衰竭、肌萎縮側索硬化症 (ALS)、癌症等嚴重疾病，以及帕金森氏症、慢性阻塞性肺病 (COPD) 和充血性心臟衰竭 (CHF) 等慢性疾病。
市場動態
新產品的推出以及主要市場參與者不斷增加的併購預計將推動全球兒科安寧療護藥物市場的成長。例如，2022年4月1日，日本製藥公司衛材株式會社收購日本醫療保健區塊鏈新創公司Arteryex Inc.，以夯實基礎並快速拓展其數位解決方案業務。兩家公司將共同開發並為患者、醫療保健專業人員和整個社會提供個人健康記錄（PHR）相關服務。
本研究的主要特點
- 本報告對全球兒科安寧療護藥物市場進行了詳細分析，並提出了以2022年為基準年的預測期（2023-2030）的市場規模和複合年增長率（CAGR）。
- 它還強調了各個細分市場的潛在收入成長機會，並為該市場提供了一系列有吸引力的投資主張。
- 它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
- 根據公司亮點、產品組合、主要亮點、績效和策略等參數對全球兒科安寧療護藥物市場的主要參與者進行了分析。
- 本研究涵蓋的主要公司包括Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
- 該報告的見解使行銷人員和公司高管能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
- 本研究報告針對該產業的各個利害關係人，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 透過用於分析全球兒科安寧療護藥物市場的各種策略矩陣，將有助於利害關係人做出決策。
目錄
第一章 研究目的與前提
- 研究目標
- 先決條件
- 縮略語
第二章 市場概況
- 報告摘要
- 市場定義和範圍
- 執行摘要
- 連貫的機會地圖 (COM)
第三章 市場動態、法規與趨勢分析
- 市場動態
- 促進者
- 抑製劑
- 市場機會
- 影響分析
- 近期產品發布
- 流行病學
- 合併、收購、聯盟
- 監管場景
- 重大發展
- PEST分析
第四章全球兒科安寧療護藥物市場：COVID-19 的影響分析
- 經濟影響
- COVID-19 的流行病學
- 對需求和供給的影響
第五章全球兒科安寧療護藥物市場：依藥物類別，2018-2030
- 止痛藥
- 止吐藥
- 瀉藥
- 輔助藥物
- 類固醇
- 鎮靜劑
- 抗精神病藥
- 其他
第六章 全球兒科安寧療護藥物市場：依給藥途徑劃分，2018-2030 年
- 口服劑
- 當地的
- 腸外
第七章 全球兒科安寧療護藥物市場：依通路劃分，2018-2030
- 醫院藥房
- 零售藥店
- 網上藥店
第八章全球兒科安寧療護藥物市場：依地區劃分，2018-2030
- 北美
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 歐洲
- 英國
- 德國
- 意大利
- 法國
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 東盟
- 澳大利亞
- 韓國
- 亞太其他地區
- 中東
- 海灣合作委員會
- 以色列
- 其他中東
- 非洲
- 北非
- 中部非洲
- 南非
第9章 競爭格局
- Novartis International AG
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Granules India Limited
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Atabay Pharmaceutical Factory
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
- Huzhou Konch Pharmaceutical Co., Ltd.
- Alnylam Pharmaceuticals Inc.
- Eton Pharmaceuticals, Inc.
- Eisai Inc.
第10章
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI4251
Global pediatric palliative care drugs market is estimated to be valued at US$ 83.1 billion in 2023 and is expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 83.1 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 5.10% | 2030 Value Projection: | US$ 117.8 Bn |
Pediatric palliative care is specialized medical care for children living with a serious illness. Palliative care focuses on providing relief from the symptoms and stress of the illness. The goal is to improve quality of life for both the child and the family. Pediatric palliative care is appropriate at any age and any stage of illness. It is appropriate for neonates, perinates, infants, children, adolescents, and young adults, and it can be provided along with treatment. Pediatric palliative care addresses serious medical conditions including genetic disorders, cancer, prematurity, neurologic disorders, heart and lung conditions, and others. It relieves the symptoms of these diseases such as pain, shortness of breath, fatigue, constipation, nausea, loss of appetite and difficulty sleeping, anxiety and depression. In short, it helps the child and the family improve their quality of life. Pediatric palliative care is an interdisciplinary collaboration that seeks to improve the quality of life for children with life-threatening conditions, as well as their families. The World Health Organization (WHO) defines pediatric palliative care as the active total care of the child's body, mind and spirit, which also involves giving support to the family. Different drugs most commonly used in palliative care are paracetamol, ibuprofen, morphine, bisacodyl, metronidazole, domperidone, dexamethasone, and diazepam. It is also used to treat serious disorders like chronic diseases such as kidney failure, Amyotrophic Lateral Sclerosis (ALS), cancer, Parkinson's disease, Chronic Obstructive Pulmonary Disease (COPD), and Congestive Heart Failure (CHF).
Market Dynamics
Increasing new product launches, and mergers and acquisitions by key market players are expected to drive the global pediatric palliative care drugs market growth. For instance, on April 1, 2022, Eisai Co., Ltd., a Japan-based pharmaceutical company announced the acquisition of Arteryex Inc., a Japan-based healthcare blockchain startup, to strengthen and rapidly expand the foundation of its digital solution business. The two companies will work together to develop and provide Personal Health Record (PHR)-related services for patients, healthcare professionals, and society at large.
Key features of the study:
- This report provides an in-depth analysis of the global pediatric palliative care drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pediatric palliative care drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pediatric palliative care drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric palliative care drugs market
Detailed Segmentation:
- Global Pediatric Palliative Care Drugs Market, By Drug Class:
- Analgesics
- Anti-emetics
- Laxatives
- Adjuvant Medications
- Steroids
- Sedatives
- Neuroleptic Medications
- Others
- Global Pediatric Palliative Care Drugs Market, By Route of Administration:
- Oral
- Topical
- Parenteral
- Global Pediatric Palliative Care Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Pediatric Palliative Care Drugs Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Novartis International AG
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Granules India Limited
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Atabay Pharmaceutical Factory
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd
- Huzhou Konch Pharmaceutical Co., Ltd.
- Alnylam Pharmaceuticals Inc.
- Eton Pharmaceuticals, Inc
- Eisai Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Pediatric Palliative Care Drugs Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Pediatric Palliative Care Drugs Market, By Drug Class, 2018-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Anti-emetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Adjuvant Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Sedatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Neuroleptic Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
6. Global Pediatric Palliative Care Drugs Market, By Route of Administration, 2018-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
7. Global Pediatric Palliative Care Drugs Market, By Distribution Channel, 2018-2030, (US$ Billion)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
8. Global Pediatric Palliative Care Drugs Market , By Region, 2018-2030, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Billion)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Granules India Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Atabay Pharmaceutical Factory
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Huzhou Konch Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alnylam Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eton Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eisai Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
